Does Medicare Cover Heart Failure Treatment — Complete Guide 2026
Does Medicare cover heart failure treatment in 2026? Heart failure — also called congestive heart failure or CHF — is one of the leading causes of hospitalization among Medicare beneficiaries with over 6 million Americans living with heart failure and the condition becoming increasingly common with age. The good news is that yes — does Medicare cover heart failure treatment in 2026 — comprehensively across all stages of heart failure management including medications, cardiac rehabilitation, device therapy, and surgical interventions. In this complete guide we explain exactly what Medicare covers for heart failure treatment in 2026. All information is sourced from Medicare.gov and CMS.gov.
Also Read —
- Does Medicare Cover Heart Surgery 2026
- Does Medicare Cover Cardiac Rehabilitation 2026
- Medicare for People Under 65 with Disability — Complete Guide 2026
What You Will Learn — Does Medicare Cover Heart Failure
- Does Medicare cover heart failure treatment in 2026
- Does Medicare cover heart failure medications
- Does Medicare cover heart failure hospitalization
- Does Medicare cover cardiac rehabilitation for heart failure
- Does Medicare cover LVAD and device therapy
- Does Medicare cover cardiac resynchronization therapy
- Does Medicare cover heart transplant for heart failure
- How much does heart failure treatment cost with Medicare
- Does Medicare Advantage cover heart failure
- Frequently asked questions about Medicare heart failure coverage 2026
Does Medicare Cover Heart Failure Treatment in 2026?
Yes — does Medicare cover heart failure treatment in 2026 — comprehensively across all stages and treatment modalities. Medicare Part B covers physician and cardiologist visits, diagnostic testing including echocardiograms and BNP levels, cardiac rehabilitation for qualifying heart failure patients, and device implantation procedures. Medicare Part D covers the full range of heart failure medications from affordable generic ACE inhibitors through expensive newer agents like sacubitril/valsartan. Medicare Part A covers hospitalization for acute heart failure decompensation — one of the most common reasons for Medicare inpatient admission.
Heart failure management requires a comprehensive multidisciplinary approach — involving medications to improve cardiac function and reduce symptoms, monitoring to detect deterioration early, cardiac rehabilitation to improve functional capacity, and in advanced cases device therapy or surgical intervention. Understanding does Medicare cover heart failure across all these treatment components helps Medicare beneficiaries with heart failure access the complete care they need.
Does Medicare Cover Heart Failure Medications?
Does Medicare cover heart failure medications in 2026? Yes — Medicare Part D covers the full spectrum of heart failure medications — from inexpensive generic drugs that have been the cornerstone of heart failure treatment for decades through newer expensive agents that have dramatically improved survival.
ACE Inhibitors — Covered at Very Low Cost
ACE inhibitors — the foundation of heart failure pharmacotherapy for reduced ejection fraction — are available as generics at very affordable prices:
- Lisinopril — generic — typically Tier 1 — approximately $5 to $15 per month
- Enalapril — generic — typically Tier 1 — approximately $5 to $15 per month
- Captopril — generic — covered Part D
- Ramipril — generic — covered Part D
ARBs — Covered at Low Cost
Angiotensin receptor blockers for patients who cannot tolerate ACE inhibitors:
- Losartan — generic — typically Tier 1 — approximately $5 to $15 per month
- Valsartan — generic — covered Part D
- Candesartan — generic available — covered Part D
Beta-Blockers — Covered at Very Low Cost
Beta-blockers for heart failure — all available as generics:
- Carvedilol (Coreg) — generic — typically Tier 1 — approximately $5 to $20 per month
- Metoprolol succinate (Toprol-XL) — generic — covered Part D
- Bisoprolol — generic — covered Part D
Sacubitril/Valsartan (Entresto) — Covered Under Part D
Sacubitril/valsartan (Entresto) is the most important newer heart failure medication — an ARNI (angiotensin receptor-neprilysin inhibitor) that has demonstrated superior outcomes compared to ACE inhibitors for heart failure with reduced ejection fraction. Entresto is covered under Medicare Part D.
Entresto costs approximately $600 to $700 per month at retail — subject to Part D formulary tier and cost-sharing. The $2,000 annual Part D out-of-pocket maximum provides important financial protection for Entresto patients — once the cap is reached Entresto is covered at $0 for the rest of the year.
SGLT-2 Inhibitors for Heart Failure — Covered Under Part D
SGLT-2 inhibitors have demonstrated remarkable benefits for heart failure patients — both with and without diabetes:
- Dapagliflozin (Farxiga) — FDA-approved for heart failure — covered Part D
- Empagliflozin (Jardiance) — FDA-approved for heart failure — covered Part D
These medications reduce heart failure hospitalizations significantly and are now recommended as standard therapy for most heart failure patients. The $2,000 annual Part D cap protects patients taking these brand-name drugs.
MRA — Mineralocorticoid Receptor Antagonists
- Spironolactone — generic — very affordable — Tier 1 most plans
- Eplerenone — generic available — covered Part D
Ivabradine (Corlanor) — Covered Part D
For heart failure patients with elevated heart rate despite beta-blocker therapy — covered under Part D.
Loop Diuretics — Covered at Very Low Cost
Essential for managing fluid retention in heart failure:
- Furosemide (Lasix) — generic — approximately $5 to $10 per month — Tier 1
- Bumetanide — generic — covered Part D
- Torsemide — generic — covered Part D
Digoxin — Covered
Digoxin — an older agent used for heart rate control in heart failure with atrial fibrillation — generic covered at very low cost.
Does Medicare Cover Heart Failure Hospitalization?
Does Medicare cover heart failure hospitalization in 2026? Yes — Medicare Part A covers inpatient hospitalization for acute decompensated heart failure — one of the most common reasons for Medicare hospitalization.
Acute Heart Failure Hospitalization Coverage
When heart failure decompensates — causing severe fluid overload, respiratory distress, or other acute symptoms — hospitalization is frequently required. Medicare Part A covers inpatient heart failure hospitalization including:
- IV diuresis and fluid management
- IV vasoactive medications — dobutamine, milrinone, nitroprusside
- Hemodynamic monitoring
- Cardiology and heart failure specialist consultations
- Cardiac imaging and testing during hospitalization
- Medication adjustment and optimization
Heart Failure Hospitalization Costs with Medicare
Part A deductible — $1,676 per benefit period Days 1 to 60 — $0 after deductible Days 61 to 90 — $419 per day coinsurance
With Medigap Plan G — heart failure hospitalization costs $0 after the $257 annual Part B deductible — covering the $1,676 Part A deductible and all daily coinsurance for extended stays.
Heart failure patients are frequently readmitted — sometimes multiple times per year. With Original Medicare each new benefit period means a new $1,676 deductible. Medigap Plan G covers each Part A deductible — providing critical protection for patients with recurrent heart failure hospitalizations.
Does Medicare Cover Heart Failure Diagnostic Testing?
Does Medicare cover diagnostic testing for heart failure in 2026? Yes — Medicare Part B covers all major heart failure diagnostic tests at 80% after the $257 annual Part B deductible.
Echocardiogram — Covered
Echocardiography — ultrasound imaging of the heart — is the primary test for evaluating heart function and ejection fraction. Medicare covers echocardiograms at 80% after the deductible for heart failure monitoring and management. Most heart failure patients have echocardiograms annually or more frequently — making Medigap Plan G particularly valuable for eliminating these recurring costs.
BNP and NT-proBNP — Covered at $0
Brain natriuretic peptide levels — BNP and NT-proBNP — are biomarkers of heart failure severity covered as diagnostic laboratory tests at $0.
Electrocardiogram — Covered
ECG for heart rhythm evaluation — covered at 80% after deductible.
Chest X-Ray — Covered
Chest radiograph for evaluating pulmonary congestion — covered at 80% after deductible.
Right Heart Catheterization — Covered
Pulmonary artery catheterization for hemodynamic assessment in advanced heart failure — covered at 80% after deductible.
Does Medicare Cover Cardiac Rehabilitation for Heart Failure?
Does Medicare cover cardiac rehabilitation for heart failure in 2026? Yes — and this is one of the most important relatively recent expansions of Medicare cardiac rehabilitation coverage.
Medicare Part B covers cardiac rehabilitation for patients with stable chronic heart failure with:
- Left ventricular ejection fraction of 35% or less
- New York Heart Association Class II to IV symptoms
Up to 36 sessions of cardiac rehabilitation are covered at 80% after the Part B deductible. With Medigap Plan G all 36 cardiac rehabilitation sessions cost $0 after the annual deductible.
Heart failure cardiac rehabilitation significantly reduces hospitalizations and improves quality of life — making this coverage expansion one of the most clinically important Medicare heart failure benefits.
Does Medicare Cover LVAD for Heart Failure?
Does Medicare cover left ventricular assist device (LVAD) implantation for heart failure in 2026? Yes — Medicare covers LVAD implantation for qualifying advanced heart failure patients.
LVAD Coverage
Medicare covers LVAD for:
- Bridge to heart transplantation — for patients awaiting a heart transplant
- Destination therapy — for patients who are not transplant candidates and require permanent mechanical support
LVAD implantation is a major cardiac surgery covered under Medicare Part A as an inpatient procedure. The $1,676 Part A deductible applies — with Medigap Plan G covering this deductible and all coinsurance.
Does Medicare Cover Cardiac Resynchronization Therapy?
Does Medicare cover cardiac resynchronization therapy (CRT) for heart failure in 2026? Yes — Medicare covers CRT devices for qualifying heart failure patients.
CRT Coverage
Cardiac resynchronization therapy — using a specialized pacemaker or defibrillator to coordinate the contractions of the heart’s ventricles — is covered for heart failure patients who meet specific clinical criteria including:
- Heart failure with reduced ejection fraction — typically 35% or less
- Left bundle branch block or other qualifying conduction abnormalities
- Persistent symptoms despite optimal medical therapy
Types of CRT Devices Medicare Covers
CRT-P — cardiac resynchronization therapy pacemaker — covered CRT-D — cardiac resynchronization therapy defibrillator — covered for patients with high sudden death risk
CRT device implantation is covered under Medicare Part B for outpatient procedures or Part A for inpatient. With Medigap Plan G CRT implantation costs $0 after the annual deductible.
Does Medicare Cover Heart Transplant for Heart Failure?
Does Medicare cover heart transplant for advanced heart failure in 2026? Yes — Medicare covers heart transplantation for qualifying end-stage heart failure patients.
Heart Transplant Coverage
Medicare covers heart transplantation at Medicare-approved transplant centers including:
- Pre-transplant evaluation — covered Part B
- The transplant surgery — covered Part A
- Post-transplant immunosuppressive medications — covered Part B and Part D
The lifetime immunosuppressive drug benefit ensures transplant patients maintain coverage for anti-rejection medications permanently — including after Medicare ESRD coverage would otherwise end.
How Much Does Heart Failure Treatment Cost with Medicare in 2026?
Heart Failure Medications Part D
Generic ACE inhibitors beta-blockers diuretics — $5 to $20 per month each — very affordable Entresto sacubitril/valsartan — $2,000 annual Part D cap applies Jardiance Farxiga for heart failure — $2,000 annual Part D cap applies
Heart Failure Hospitalization
Per hospitalization with Original Medicare — $1,676 Part A deductible Multiple hospitalizations per year — $1,676 per benefit period each With Medigap Plan G — $0 per hospitalization after annual deductible — critical for recurrent admissions
Echocardiogram Monitoring
With Original Medicare — approximately $60 to $100 your 20% per echo Annual echo — $60 to $100 without supplement With Medigap Plan G — $0 per echocardiogram after annual deductible
Cardiac Rehabilitation
With Original Medicare — approximately $720 to $1,440 for 36 sessions your 20% With Medigap Plan G — $0 after annual deductible
LVAD and CRT Devices
Major procedures — significant Part A deductible and Part B coinsurance without supplement With Medigap Plan G — $0 after annual deductible
Does Medicare Advantage Cover Heart Failure?
Does Medicare Advantage cover heart failure treatment in 2026? Yes — all Medicare Advantage plans must cover heart failure treatment as Medicare-required services.
Enhanced heart failure programs — many Medicare Advantage plans offer:
- Remote monitoring programs — weight scales blood pressure monitors provided
- Care managers and nurse coordinators for heart failure
- Proactive outreach to prevent hospitalizations
- Telehealth cardiology consultations at $0
Prior authorization — required for LVAD CRT and other major procedures. In-network cardiologist and hospital — verify before scheduling procedures. Annual maximum $9,350 — heart failure patients with multiple hospitalizations may reach this quickly.
Part D maximum $2,000 — same protection for Entresto and SGLT-2 inhibitors.
Frequently Asked Questions — Does Medicare Cover Heart Failure
Does Medicare cover heart failure treatment in 2026?
Yes — does Medicare cover heart failure comprehensively in 2026 including cardiologist visits, all medications from affordable generics through Entresto and SGLT-2 inhibitors under Part D with $2,000 annual cap, hospitalization under Part A, cardiac rehabilitation, echocardiograms, LVAD, CRT devices, and heart transplantation. With Medigap Plan G most heart failure treatment costs $0 after the annual deductible.
Does Medicare cover Entresto for heart failure?
Yes — Medicare Part D covers sacubitril/valsartan (Entresto) for heart failure with reduced ejection fraction. Entresto costs approximately $600 to $700 per month at retail — the $2,000 annual Part D maximum cap provides important financial protection limiting total annual drug costs to $2,000.
Does Medicare cover heart failure hospitalization?
Yes — Medicare Part A covers inpatient hospitalization for acute decompensated heart failure. The $1,676 Part A deductible applies per benefit period. Heart failure patients frequently have multiple hospitalizations per year — with Medigap Plan G covering each deductible making repeated heart failure hospitalizations effectively free after the annual deductible.
Does Medicare cover Jardiance for heart failure?
Yes — Medicare Part D covers empagliflozin (Jardiance) for heart failure — both with and without diabetes. Jardiance has demonstrated significant reduction in heart failure hospitalizations and is now recommended standard therapy. The $2,000 annual Part D maximum protects patients from Jardiance’s high retail cost.
Does Medicare cover cardiac rehabilitation for heart failure?
Yes — Medicare Part B covers up to 36 cardiac rehabilitation sessions for stable heart failure with ejection fraction 35% or less and NYHA Class II to IV symptoms at 80% after the deductible. With Medigap Plan G all 36 sessions cost $0 after the annual deductible.
Summary — Does Medicare Cover Heart Failure 2026
Does Medicare cover heart failure treatment in 2026? Yes — Medicare provides comprehensive heart failure coverage across all treatment modalities including affordable generic medications, Entresto and SGLT-2 inhibitors protected by the $2,000 Part D annual cap, hospitalization, cardiac rehabilitation, echocardiographic monitoring, LVAD, CRT device therapy, and heart transplantation.
For heart failure patients Medigap Plan G provides extraordinary financial protection — covering multiple annual hospitalization deductibles that can multiply rapidly for patients with recurrent admissions, eliminating echocardiogram and cardiac rehabilitation costs, and protecting against all Part B coinsurance on device procedures. Heart failure patients are among those who benefit most from Medigap Plan G given their high frequency of Medicare-covered service utilization.
For free help understanding your Medicare heart failure coverage contact your State Health Insurance Assistance Program (SHIP) at shiphelp.org or call Medicare free at 1-800-633-4227.
This guide is for informational purposes only. Always consult your cardiologist and verify current Medicare coverage at Medicare.gov.
Sources: Medicare.gov | CMS.gov | SSA.gov | AARP.org
Last updated: April 2026 | Author: James Carter, Independent Medicare Research Analyst
